When Escherichia coli strain B/r is exposed to 10 to 20 ug of nitrofurazone per ml, mutants with roughly threefold resistance are obtained. Treatment of these mutants with higher concentrations of nitrofurazone yields strains with six-to sevenfold resistance over strain B/r. Each of these steps toward nitrofurazone resistance is accompanied by loss of soluble nitrofurazone reductase activity. When sensitive bacteria are exposed to labeled nitrofurazone or labeled 2-nitrofuran, a considerable amount of radioactivity becomes bound to the cold trichloroacetic acid-insoluble fraction. Very little activity becomes bound in the mutants with six-to seven-fold resistance; mutants with intermediate resistance show intermediate levels of binding. Partially purified nitrofurazone reductase preparations catalyze the conversion of nitrofurazone to compounds which bind to protein and are not removed by prolonged dialysis against 8 M urea or by cold acid. Nitrofurazone reduced by xanthine oxidase or electrolytically reduced also yields compounds which react with protein to form stable derivatives.
The antibacterial properties of nitrofurans were first recognized by groups in the United States (4) and Germany (3) during the 1940's. Since that time, certain derivatives have been widely used in clinical and veterinary medicine. More recently, these and related compounds have been shown to have other biological effects (6, 7, 14, 15, (18) (19) (20) (26) (27) (28) (29) .
Asnis showed some years ago that strains of bacteria which are sensitive to nitrofurazone contain a flavoprotein which catalyzes reduction of the drug (1) . Since this reductase was not present in resistant strains, he concluded that it converts nitrofurazone to a compound which damages cells. In this paper we describe the isolation and properties of two types of nitrofurazone-resistant mutants. The first class has threefold resistance and is partially lacking in nitrofurazone reductase. Mutants of the second class are more highly resistant and are almost totally lacking in detectable soluble reductase activity. We also show that although '4C-labeled nitrofurazone becomes bound to the cold-trichloroacetic acid-insoluble fraction of sensitive cells, little binding occurs in the most highly resistant mutants. Reduction of l4C-nitrofurazone by bacterial nitrofurazone reductase or xanthine oxidase produces a compound which reacts with protein. Electrochemical reduction of nitrofurazone under controlled conditions also produces a compound which reacts with protein.
MATERIALS AND METHODS Chemicals. 2-Nitrofuran was prepared by nitration of furan (5) and 5-nitro-2-furaldehyde from the diacetate (10) . Nitrofurazone (5-nitro-2-furaldehyde semicarbazone) was a gift from Norwich Pharmacal, Norwich, N.Y. Glucose-6-phosphate dehydrogenase and xanthine oxidase were obtained from Worthington Biochemical Corp. Pyridine nucleotides and bovine serum albumin were purchased from Sigma Chemical Co. Serum albumin was acetylated by the procedure of Fraenkel-Conrat et al. (8) .
Preparation of labeled nitrofurans: "4C-nitrofurazone. Nitrofuraldehyde was condensed with l4(C labeled semicarbazide-hydrochloride (International Chemical and Nuclear Corp.) by using the standard procedure (22) . The product had a specific activity of 2 mCi/mmole. Tritiated 2-nitrofuran. A sample of pure 2-nitrofuran was tritiated by the Radiochemical Centre, Amersham, England. The material was returned in the form of an ethanolic solution which contained several radioactive compounds including a relatively small proportion of 2-nitrofuran. One milliliter of the ethanolic solution was added to 30 ml of benzene and the ethanol removed by fractional distillation. (Nitrofuran has a relatively high-vapor pressure and this procedure minimizes losses.) The benzene solution was applied to a silica gel column which was then eluted with benzene. Nitrofuran is the first major compound to emerge from the column. The benzene was carefully evaporated to yield 2-nitrofuran which appeared to be radiochemically pure when analyzed by thin-layer chromatography in several solvents. The specific activity of the tritiated 2-nitrofuran was approximately 20 mCi/mmole.
ACTION OF NITROFURAZONE
An alternative method of purifying labeled 2-nitrofuran was used when only small amounts of material were required. The mixture was chromatographed on a 0.75-mm layer of silica gel GF-240 on a thin-layer plate (20 by 20 cm) by using benzene as the solvent. The ultraviolet (UV)-absorbing band corresponding to nitrofuran was scraped off; the compound was extracted with hot ethanol, concentrated to about 2 ml, and stored as a stock solution.
Electrochemical reduction of nitrofurans. Determination of radioactivity. To determine the incorporation of radioactivity into bacteria or protein (16) , small samples of the culture or reaction mixture were pipetted onto small filter-paper discs which were then placed in ice-cold 5% trichloroacetic acid; washed once in trichloroacetic acid, twice in ethanol, and once in acetone; dried; placed in scintillation vials; and counted in a Nuclear-Chicago Unilux I scintillation counter by using fluid containing 160 ml of Spectrofluor (Amersham/Searle Corp.) per gallon of toluene.
RESULTS AND DISCUSSION
As has been noted by previous workers (14, 28) , treatment of E. coli B with nitrofurazone or other nitrofuran derivatives yielded mutants with about 10-to 20-fold resistance. These mutants were cross-resistant to UV radiation, having the sensitivity of E. coli B/r. Similarly, E. coli B/r is resistant to a variety of nitrofurans. This step in the acquisition of nitrofurazone resistance is not associated with the loss of nitrofurazone reductase activity and presumably is a consequence of the ability of B/r strains to survive damage in deoxyribonucleic acid (DNA) (11, 21) .
When stationary-phase cultures of E. coli B/r were successively plated on media containing increasing concentrations of nitrofurazone, strains resistant to 40 to 50 ,ug of the drug per ml were easily obtained. We original plating. Much of our early work was done with such strains, and some of the data thus obtained are included. However, we found that, when cultures of E. coli B/r were spread on nutrient agar plates containing 10 to 20 ,ug of nitrofurazone per ml, the few colonies which appeared were resistant to 12 to 15 ,ug of nitrofurazone per ml. Twenty-six independent mutants of this type were replated on nutrient agar, and cultures derived from a single colony of each were used for further work. These strains were numbered nfr-101 to nfr-126. When such strains were streaked on gradient plates containing nitrofurazone, a few individual colonies were found growing well beyond the area of confluent growth. These colonies were picked and tested, and all were found to have acquired resistance to between 35 and 45 Mug of nitrofurazone per ml. These strains were numbered nfr-201 to nfr-226 (nfr-201 being derived from nfr-101 and so on).
Five strains of each series were selected arbitrarily for further study. Strains resistant to nitrofurazone showed cross resistance to other nitrofurans but were just as sensitive as B/r to unrelated agents such as nitrosoguanidine and streptomycin. Figure 1 When an extract of strain nfr-207 was mixed with an extract of strain B/r, the reductase activity was identical to that obtained when the E. coli B/r extract was diluted with a comparable volume of buffer. Thus, there is no evidence for the presence of inhibitors, at least in strain nfr-207. These observations strongly suggest that in these strains resistance to nitrofurazone is a direct consequence of loss of the reductase. Table 1 summarizes results obtained during the partial purification of the reductase from E. coli B/r. A 10-fold increase in specific activity was obtained with an overall yield of 26%. The purest preparations had a specific activity of 0.33 Amole per min per mg of protein. Figure 3 shows that preparations of B/r nitrofurazone reductase, partially purified by precipitation with 40 to 60% ammonium sulfate, catalyzed the rapid reduction of nitrofurazone, whereas the corresponding fraction from nfr-40 was very much less active. Addition of glucose-6-phosphate dehydrogenase to the partially purified enzyme from B/r increased the rate of reduction by a factor ofalmost 3, showing that the regeneration of NADPH is the rate-limiting step in such partially purified preparations with NADP or catalytic amounts of NADPH as cofactor. No stimulation was obtained when glucose-6-phosphate dehydrogenase was added to a similar preparation from nfr-40. The initial increase in the optical density of the assay mixture with nfr-40 extracts supplemented with the dehydrogenase is likely due to the accumulation of NADPH in the reaction mixture since this compound does have some absorption at 375 nm.
Nitrofurazone reductase preparations also reduce other nitrofuran derivatives of various structural types, including nitrofurantoin, 2-Nformyl-amino-(5-nitro-2-furyl)-thiazole, and 3- at rates comparable to that for nitrofurazone ( Table 2) . 2-Nitrofuran, however, is reduced much more slowly.
Intact cells of nfr-211, -222, -225, and related strains destroy nitrofurazone at a rate which is considerably higher in relation to the rate found for strain B/r (Fig. 1) Fig. 4 were collected, washed, sonically treated in 0.066 M potassium phosphate buffer (pH 7.2); the resulting suspension was centrifuged at 10,000 X g for 30 min. The trichloroacetic acid-insoluble radioactivity in samples of the extract treated for 1 hr with 1 mg of Pronase per ml was only 40% of that obtained from control samples (not exposed to Pronase). Treatment with ribonuclease and deoxyribonuclease did not result in a measurable decrease in acid-insoluble counts. This result provides tentative evidence that much of the radioactivity bound to cellular material is associated with protein. This labeling was not merely the result of incorporation of amino acids containing label from degradation products of the nitrofurazone into protein, since the amount of radioactivity which became associated with protein was not decreased by 20 ,ug of chloramphenicol per ml, a concentration which reduced leucine incorporation to less than 11% of the control rate.
Because the labeled nitrofurazone available contained 'IC in the semicarbazide moiety and not in the furan ring, it was thought desirable to test the incorporation of some other ring-labeled compound. Since 2-nitrofuran is known to have (Tables 4 and 5 ). Enzyme preparations partially purified by ammonium sulfate precipitation and Sepharose chromatography also catalyzed incorporation of radioactivity from nitrofurazone into protein (Table 6 ). In experiment 1 the complete reaction mixture contained: 4 mg of serum albumin, 0.1 mg of NADPH, 20 pmoles of glucose-6-phosphate, 0.5 ml of ammonium sulfate purified enzyme (about 2.5 mg of protein), and 50 ug (0.5 gCi) of 14C nitrofurazone in a final volume of 2.6 ml. In experiment 2, the complete reaction mixture contained 5 mg of serum albumin, Sepharose-purified enzyme (0.05 mg of protein), I mg of NADPH, and 50 Mug (0.5 pCi) of 14C-nitrofurazone in a final volume of 2.6 ml. Samples (10 pliters) were taken for counting.
b Counts per minute bound during indicated intervals.
ammonium sulfate stage of purification were used, the amount of trichloroacetic acid-insoluble radioactivity was relatively high even when no albumin was added (Table 6 ). This was undoubtedly a consequence of the high protein content of the reaction mixture. When small amounts of more highly purified preparations were used, there was a considerable increase in the acidinsoluble counts when serum albumin was added. Since the rate of reduction is not influenced by the addition of serum albumin to the reaction mixture, it is unlikely that the observed increase in counts is due to stabilization of the enzyme or to other indirect effects. This conclusion is strengthened by the results of labeling experiments (e.g., (Table 7) . Table 8 shows that nitrofurazone reductase also "activates" 2-nitrofuran so that it reacts with protein.
Taylor et al. have reported that xanthine oxidase also reduces nitrofurazone (25) . Since about 1 mole of hypoxanthine is converted to uric acid during the reduction of 1 mole of nitrofurazone, they suggest that the reduction product is the corresponding hydroxylaminofuran. Table  9 shows that purified xanthine oxidase also "activates" nitrofurazone to produce compounds Conduding renarks. From these experiments it appears that the reactive compound is likely 5-hydroxylamino-2-furaldehyde semicarbazone, the product of electrochemical reduction and the inferred product of reduction by xanthine oxidase. Although there is no definitive information as to the identity of the active product formed by the bacterial enzyme, it seems reasonable to conclude that the hydroxylamino derivative may be involved since it is undoubtedly formed as an intermediate in the reduction process (9) . Hydroxylamino derivatives of other aromatic compounds are known to react with protein and nucleic acid and to have a wide range of biological effects (12, 17) .
The possible physiological relevance of the reaction described above is shown by the observation that there is very much less incorporation of 'IC from nitrofurazone into cells of the resistant strain than into cells of sensitive strains, a difference which can also be demonstrated in cell-free extracts. This is not, of course, to say that the reaction with protein is necessarily the were taken for counting. 
